Can we control all-cause meningococcal disease in Europe?

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Vaccines for the elderly
Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,
Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,
P. Gautret, E. Botelho-Nevers, P. Brouqui, P. Parola 
J. Moran-Gilad, E. Kaliner, M. Gdalevich, I. Grotto 
C.N. van Ettekoven, D. van de Beek, M.C. Brouwer 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia 
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects  K. Ekelund, P. Skinhøj, J. Madsen, H.B.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Education in infection control: A need for European certification
Refugee crisis and re-emergence of forgotten infections in Europe
Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children  N. Agrinier, M. Le Maréchal,
Public health significance of invasive mosquitoes in Europe
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Clinical Microbiology and Infection
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
P. O'Connor, D. Jankovic, M. Muscat, M. Ben-Mamou, S. Reef, M
Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine  E. Calbo, Á. Díaz, E.
Vector control: a cornerstone in the malaria elimination campaign
Towards the risk of yellow fever transmission in Europe
P.L. Lopalco, P. Carrillo Santisteve 
E. Vermeulen, J. Maertens, P. Meersseman, V. Saegeman, L. Dupont, K
B. Gordts  Clinical Microbiology and Infection 
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years  T.G. Harrison, N. Doshi, N.K. Fry, C.A.
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Previously unknown species of Aspergillus
Enterovirus infections in England and Wales, 2000–2011: the impact of increased molecular diagnostics  S. Kadambari, A. Bukasa, I.O. Okike, R. Pebody,
The practice of travel medicine in Europe
Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989–2008)  C. Esteva, L. Selva, M.F.
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Community-acquired pneumonia: epidemiologic and clinical consideration
The role of antimalarial treatment in the elimination of malaria
Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.
Vaccinations against respiratory tract infections at Hajj
Vaccines for the elderly
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Influence of climate change on the incidence and impact of arenavirus diseases: a speculative assessment  J.C. Clegg  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Great oaks from little acorns grow—21 years of CMI
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Can we control all-cause meningococcal disease in Europe? M. Sadarangani, A.J. Pollard  Clinical Microbiology and Infection  Volume 22, Pages S103-S112 (December 2016) DOI: 10.1016/j.cmi.2016.03.006 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Map of notification rates per 100 000 population of invasive meningococcal disease in Europe in 2012. Source: European Centre for Disease Prevention and Control (http://ecdc.europa.eu/en/data-tools/atlas/Pages/atlas.aspx). Clinical Microbiology and Infection 2016 22, S103-S112DOI: (10.1016/j.cmi.2016.03.006) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Notification rate of confirmed cases of invasive meningococcal disease by age group and sex in Europe in 2012. Total number of cases included was 3439 [20]. Source: European Centre for Disease Prevention and Control. Clinical Microbiology and Infection 2016 22, S103-S112DOI: (10.1016/j.cmi.2016.03.006) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 3 Impact of MCCs on MenC disease in Europe [21,22]. (Top) Reduction in incidence rate of confirmed and probable MenC disease (1999–2006) in countries that did include MCC in their routine vaccination schedule but not in those countries without MCC. (Bottom) Incidence rates of MenC disease by vaccination policy in countries within Europe. MCC, meningococcal capsular group C conjugate vaccine; MenC, meningococcal capsular group C. Source: European Centre for Disease Prevention and Control. Clinical Microbiology and Infection 2016 22, S103-S112DOI: (10.1016/j.cmi.2016.03.006) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 4 Number of cases of meningococcal disease over time in England and Wales, 1912–2012 [23] (a) and 2005–2015 [25] (b) Reference lines for England estimates are based on hospital episode statistical data. Source: BMJ (a) and Public Health England (b). Clinical Microbiology and Infection 2016 22, S103-S112DOI: (10.1016/j.cmi.2016.03.006) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions